[HTML][HTML] The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer

C Colombo, E Minna, C Gargiuli, M Muzza… - … & Clinical Cancer …, 2020 - Springer
… b Clinical and molecular features of the patients included in the 3 different RAI classes.
Note … of fusion genes in PTCs with initial RAI uptake, but without therapeutic efficacy (RAI+/D+), …

Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes

J Simões-Pereira, A Saramago, R Rodrigues, M Pojo… - Endocrine, 2024 - Springer
molecular markers that may help to predict RAI avidity and RAI therapy response of metastatic
lesions in a cohort of papillary thyroid cancer (PTC… significant did not evidence RAI uptake. …

[HTML][HTML] Molecular features of aggressive thyroid cancer

G Elia, A Patrizio, F Ragusa, SR Paparo… - Frontiers in …, 2022 - frontiersin.org
no kind of correlation between BRAF V600E and any of the PTC aggressiveness features
(… of the capacity to uptake RAI after a previous WBS showing avidly uptake RAI metastases; a …

TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131i uptake in metastases

Z Meng, M Matsuse, V Saenko, S Yamashita… - IUBMB …, 2019 - Wiley Online Library
… in not only development of papillary thyroid carcinoma (PTC) but also determination of its
properties. The … in PTC has unveiled an uncharted territory of molecular diagnosis for predicting …

[HTML][HTML] Analysis of factors influencing the clinical outcome after surgery and 131I therapy in patients with moderate-risk thyroid papillary carcinoma

Y Li, M Rao, C Zheng, J Huang, D Fang… - Frontiers in …, 2022 - frontiersin.org
… type of thyroid carcinoma is papillary thyroid carcinoma (PTC), … , the residual thyroid tissue
before 131 I treatment was not … I uptake rate, which is closely related to the residual thyroid

[HTML][HTML] Thyroid functional and molecular imaging

L Giovanella, AM Avram, PP Ovčariček, J Clerc - La Presse Médicale, 2022 - Elsevier
… and may not parallel the absolute radiotracer uptake. In other … uptake is found in thyroid
cancer compared to normal thyroid … included papillary thyroid carcinoma (PTC) which is cancer

[PDF][PDF] progression free survival related to F-FDG PET/CT 131 uptake and I uptake in lung metastases of differentiated thyroid cancer

X Zhu, S Wu, H Wang - Hell J Nucl Med, 2019 - nuclmed.gr
… scan uptake and also of iodine-131 ( I) in DTC patients with PM. Subjects and Methods: Out
Molecular targeting drugs may be indicated in these patients. A couple of studies evaluated …

[HTML][HTML] Predictive value of LN metastasis detected by 18F‑FDG PET/CT in patients with papillary thyroid cancer receiving iodine131 radiotherapy

C Li, J Zhang, H Wang - Oncology Letters, 2019 - spandidos-publications.com
… with papillary thyroid carcinoma (PTC) with a negative iodine131 (… In conclusion, tracer
uptake of 18F‑FDG for cervical … 131I radiotherapy is not only appropriate for primary tumors

[HTML][HTML] Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies

M Aashiq, DA Silverman, S Na'ara, H Takahashi… - Cancers, 2019 - mdpi.com
… , many thyroid cancer patients have tumors that no longer … in 11 of 498 papillary thyroid
cancers (PTCs) (2.2%) and 3 of … -mutated thyroid cancer, resulting in restoration of RAI uptake

… on the Relationship of BRAF Mutations with the Outcome of the First 131I Radiotherapy and Malignant Biological Characteristics in Papillary Thyroid Carcinoma

L Shangguan, P Zhang, S Fang, K Xiang… - … Journal of General …, 2021 - Taylor & Francis
tumor molecular profile in anaplastic thyroid cancer (ATC). Citation16 However, the clinical
significance of gene mutations in ctDNA in PTC has not … and 131 I uptake test and possible …